The company currently focuses on disorders in the complement or coagulation systems, but has the potential to address additional diseases. Catalyst Biosciences is a research and clinical ...

This indicated an abnormal activation of the complement system, leading to altered blood coagulation and tissue injury, a condition known as 'thrombo-inflammation'. These findings, along with ...